Insiders Were Right: MKSI Makes New 52-Week High

In trading on Thursday, shares of MKS Instruments, Inc. (MKSI) touched a new 52-week high of $32.50/share. That's a 31.90% rise, or $7.86 per share from the 52-week low of $24.64 set back on 04/22/2013. That means at today's intraday high, any investor who purchased MKSI stock any time over the past 52 weeks has an unrealized gain, including company insiders.

Over the past six months, insiders have been scooping up shares, and those bets are now paying off handsomely. As summarized by the table below, MKSI has seen 3 different instances of insiders buying over the trailing six month period.

START SLIDESHOW:
Ten Bargains You Can Buy Cheaper Than The Insiders Did »

Purchased Insider Title Shares Price/Share Value
11/29/2013 Seth H. Bagshaw Vice President, CFO, Treasurer 443 $23.96 $10,624.99
11/29/2013 Paul Eyerman VP & GM, ENI and Medical 274 $23.96 $6,562.52
11/29/2013 John Tseng-chung Lee Sr. VP, HPS, Controls & PFMC 443 $23.96 $10,624.99

The chart below shows where MKSI has traded over the past year, with the 50-day and 200-day moving averages included.

MKS Instruments, Inc. Moving Averages Chart

In afternoon trading on Thursday, MKSI shares are changing hands at $30.60/share, slightly below the new 52-week high.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says